Hanmi to get approval of generic Nexium in US

Published: 2010-10-28 06:55:00
Updated: 2010-10-28 06:55:00
Hanmi Pharm says it has recently filed an ANDA application for its generic Nexium to the U.S. Food and Drug Administration after completion of clinical trials overseas.

The company plans to obtain the market authorization by the end of next year as the US market for Nexium stands at around $3 ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.